glp-1 receptor agonists in idiopathic intracranial hypertension After Abrupt Cessation of Medication: A Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) Agonist Cessation and Review of the Literature Idiopathic Intracranial Hypertension and the
Description
1.1 per 1,000 person-years

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down

If your primary concern is blood sugar management and diabetes care, Ozempic may be the preferred choice

MacDonald, P

Balanced Perspective: Conditional Game Changer The evidence suggests that GLP-1 agonists represent a conditional game changertransformative for appropriate patients with adequate access and support, but with significant limitations that prevent universal application
